BullFrog AI Founder and CEO Vin Singh to Present Company Overview at BioFuture 2023
GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its founder and CEO Vin Singh will give a presentation at BioFuture 2023 (Oct. 4-6, 2023) on the Company’s recent partnerships, revenue and growth strategy, and portfolio of prodrugs in early-stage clinical development. The presentation will take place on October 5, 2023 at Lotte New York Palace in New York City.
Presenter: Vin Singh, Founder and CEO, BullFrog AI
Date/Time: October 5, 2023 2:30-3:30 p.m. EDT
Location: Adams - Fourth Floor - Lotte New York Palace, 455 Madison Avenue, New York, NY
About BullFrog AI
Safe Harbor Statement
SOURCE: BullFrog AI Holdings, Inc.
Using Content-Based Analytics to Mitigate Adverse Call Labeling of Legitimate Enterprise Communications
Imagine A World Without Hold Times â€“ An AI Optimist Explains
Keynote Panel: The Continued Rise of AI: Embracing the Known and Unknown to Drive Business Results